American Shared Hospital Services (AMS)
AMS trades on NYSE in Health Care, Medical Specialities. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$1.27
0.00% on the day
Market cap
$8.4M
Nano cap
Revenue · 2025
$28.1M
-0.9% on 2024
Net income · 2025
-$1.6M
-5.5% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | AMS on NYSE |
| Sector | Health Care |
| Industry | Medical Specialities |
| Country | United States |
| IPO year | 1988 |
| SEC CIK | 0000744825 |
| SEC industry code | Services-Medical Laboratories |
| Incorporated in | CA |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $28.1M |
| Net income | -$1.6M |
| Operating income | -$3.6M |
| Net margin | -5.5% |
| Operating margin | -12.8% |
| Revenue growth | -0.9% |
| Cash | $3.5M |
| Total assets | $55.5M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 0.3× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document FORM 424B3 | 424B3 | 2015-09-21 |
| Latest annual report FORM 10-K | 10-K | 2026-03-31 |
| Latest quarterly / interim FORM 10-Q | 10-Q | 2026-08-13 |
| Latest current report FORM 8-K | 8-K | 2026-08-13 |
| Latest proxy FORM DEFA14A | DEFA14A | 2026-05-07 |
Source: SEC EDGAR submissions feed, 773 recent filings. All filings on EDGAR.
Peers in Medical Specialities
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| ADVB | Advanced Biomed Inc. | $5.16 | -2.18% | $8.5M |
| ACON | Aclarion Inc. | $2.14 | -4.68% | $6.2M |
| BGLC | BioNexus Gene Lab Corp | $1.32 | -5.01% | $3.9M |
| ACH | Accendra Health Inc. | $0.3151 | -19.31% | $24.2M |
| MDXH | MDxHealth SA | $0.6600 | +9.29% | $63.0M |
| SERA | Sera Prognostics Inc. | $2.04 | -1.45% | $80.5M |
| KEQU | Kewaunee Scientific Corporation | $32.20 | -0.62% | $93.2M |
| BNR | Burning Rock Biotech Limited | $15.00 | 0.00% | $158.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier